|
Market Closed -
Nasdaq
04:00:00 2026-04-20 pm EDT
|
5-day change
|
1st Jan Change
|
|
3.820 USD
|
+8.52%
|
 |
+19.00%
|
-6.14%
|
|
Feb. 24 |
MetLife, Inc. Announces Board Appointments, Effective February 24, 2026
|
CI
| |
Feb. 17 |
Sana Biotechnology, Inc. Appoints Brian Piper as Chief Financial Officer, Effective February 17, 2026
|
CI
| |
Feb. 17 |
Sana Biotechnology, Inc. Announces Executive Changes
|
CI
| |
25-09-05 |
Sana Biotechnology, Inc. Announces Executive Changes, Effective October 20, 2025
|
CI
| |
25-08-29 |
Sana Biotechnology, Inc. Announces Resignation of Mary Agnes Wilderotter from Board, Chairperson of the Nominating and Corporate Governance Committee of the Board and A Member of the Audit Committee of the Board, Effective August 29, 2025
|
CI
| |
25-08-06 |
Sana Biotechnology, Inc. Announces Resignation of Sonja Schrepfer as Senior Vice President and Head of the Hypoimmune Platform
|
CI
| |
24-10-08 |
Sana Biotechnology, Inc. Announces Executive Changes
|
CI
| |
24-09-26 |
Sana Biotechnology Insider Sold Shares Worth $1,195,740, According to a Recent SEC Filing
|
MT
| |
24-09-12 |
Sana Biotechnology CFO Nathan Hardy to Resign
|
MT
| |
24-09-12 |
Sana Biotechnology, Inc. Announces Nathan Hardy Intends to Resign as Chief Financial Officer, Effective October 4, 2024
|
CI
| |
24-09-12 |
Sana Biotechnology, Inc. Announces Resignation of Nathan Hardy as Executive Vice President, Effective October 4, 2024
|
CI
| |
24-08-26 |
Sana Biotechnology Names Dhaval Patel Chief Scientific Officer
|
MT
| |
24-08-26 |
Sana Biotechnology, Inc. Announces the Appointment of Dhaval Patel as Executive Vice President and Chief Scientific Officer
|
CI
| |
24-04-18 |
Sana Biotechnology, Inc. Announces Resignation of Douglas Williams as Executive Vice President and President, Research and Development
|
CI
| |
24-02-16 |
Viridian Therapeutics Names Jennifer Tousignant as Chief Legal Officer
|
MT
| |
24-02-12 |
Sana Biotechnology Insider Bought Shares Worth $9,999,996, According to a Recent SEC Filing
|
MT
| |
24-02-12 |
Sana Biotechnology Insider Bought Shares Worth $9,999,996, According to a Recent SEC Filing
|
MT
| |
23-12-18 |
Sana Biotechnology Insider Sold Shares Worth $300,098, According to a Recent SEC Filing
|
MT
| |
23-04-10 |
Sana Biotechnology Names Gary Meininger Chief Medical Officer
|
MT
| |
23-04-10 |
Sana Biotechnology, Inc. Announces Executive Changes
|
CI
| |
23-02-17 |
Insider Buy: Sana Biotechnology
|
MT
| |
22-06-02 |
Sana Biotechnology, Inc. Announces Board Appointments
|
CI
| |
21-10-15 |
Illumina : Appoints Bob Ragusa as GRAIL's CEO
|
MT
| |
21-09-17 |
Insider Sell: Sana Biotechnology
|
MT
| |
21-09-13 |
Insider Sell: Sana Biotechnology
|
MT
|
No results for this search Select your edition All financial news and data tailored to specific country editions | 
